Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.

Neurology - 1 Oct 2013

Jiao Yujuan, Fryer James P, Lennon Vanda A, Jenkins Sarah M, Quek Amy M L, Smith Carin Y, McKeon Andrew, Costanzi Chiara, Iorio Raffaele, Weinshenker Brian G, Wingerchuk Dean M, Shuster Elizabeth A, Lucchinetti Claudia F, Pittock Sean J

Abstract excerpt

OBJECTIVE: To 1) determine, using contemporary recombinant antigen-based assays, the aquaporin-4 (AQP4)-immunoglobulin G (IgG) detection rate in sequential sera of patients assigned a clinical diagnosis of neuromyelitis optica (NMO) but initially scored negative by tissue-based indirect immunoflu...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fluorescent Antibody Technique, Indirect
Share to Immunoglobulin G

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aquaporin 4

Share to Biomarkers

Share to Comorbidity

Share to Neuromyelitis Optica

Share to Phenotype

Share to Transfection

Source

Open in PubMed Open full text

Identifiers

PMID: 23997151
DOI: 10.1212/WNL.0b013e3182a6cb5c
PMCID: PMC3795610

Genes

AQP4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23997151-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.PMID 23997151Read ↗

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.Semantic proximity Read ↗

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.Semantic proximity Read ↗

The prevalence and clinical phenotype of dual seropositive neuromyelitis optica spectrum disorders at a national reference center in South Asia.Semantic proximity Read ↗

NMO‐IgG: A Specific Biomarker for Neuromyelitis OpticaSemantic proximity Read ↗

Neuromyelitis optica (NMO)--an autoimmune disease of the central nervous system (CNS).Semantic proximity Read ↗

Serum AQP4-IgG level is associated with the phenotype of the first attack in neuromyelitis optica spectrum disorders.Semantic proximity Read ↗

Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.Semantic proximity Read ↗

Beyond MOG and AQP4 Antibodies: Alternative Causes of Optic NeuritisSemantic proximity Read ↗

Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.Semantic proximity Read ↗

Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.Semantic proximity Read ↗

Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution.Semantic proximity Read ↗

Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.